BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11214784)

  • 1. Attitudes to reporting adverse drug reactions in northern Sweden.
    Bäckström M; Mjörndal T; Dahlqvist R; Nordkvist-Olsson T
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):729-32. PubMed ID: 11214784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden.
    Ekman E; Bäckström M
    Eur J Clin Pharmacol; 2009 Jan; 65(1):43-6. PubMed ID: 18825377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse drug reaction reporting by nurses in Sweden.
    Bäckström M; Ekman E; Mjörndal T
    Eur J Clin Pharmacol; 2007 Jun; 63(6):613-8. PubMed ID: 17404719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudinal survey of voluntary reporting of adverse drug reactions.
    Eland IA; Belton KJ; van Grootheest AC; Meiners AP; Rawlins MD; Stricker BH
    Br J Clin Pharmacol; 1999 Oct; 48(4):623-7. PubMed ID: 10583035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicians' attitudes and adverse drug reaction reporting : a case-control study in Portugal.
    Herdeiro MT; Figueiras A; Polónia J; Gestal-Otero JJ
    Drug Saf; 2005; 28(9):825-33. PubMed ID: 16119975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospital pharmacists' knowledge and opinions regarding adverse drug reaction reporting in Northern China.
    Su C; Ji H; Su Y
    Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):217-22. PubMed ID: 20033911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge, attitude and practice of General Practitioners towards adverse drug reaction reporting in South of Iran, Shiraz (Pharmacoepidemiology report).
    Peymani P; Tabrizi R; Afifi S; Namazi S; Heydari ST; Shirazi MK; Nouraei H; Sadeghi E; Lankarani KB; Maharlouei N
    Int J Risk Saf Med; 2016 Mar; 28(1):25-31. PubMed ID: 27176754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom.
    Belton KJ; Lewis SC; Payne S; Rawlins MD; Wood SM
    Br J Clin Pharmacol; 1995 Mar; 39(3):223-6. PubMed ID: 7619660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attitudes to adverse drug reaction reporting in the Northern Region.
    Bateman DN; Sanders GL; Rawlins MD
    Br J Clin Pharmacol; 1992 Nov; 34(5):421-6. PubMed ID: 1467137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous reporting of adverse drug reactions by nurses.
    Bäckström M; Mjörndal T; Dahlqvist R
    Pharmacoepidemiol Drug Saf; 2002 Dec; 11(8):647-50. PubMed ID: 12512239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A small economic inducement to stimulate increased reporting of adverse drug reactions--a way of dealing with an old problem?
    Bäckström M; Mjörndal T
    Eur J Clin Pharmacol; 2006 May; 62(5):381-5. PubMed ID: 16572320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. The European Pharmacovigilance Research Group.
    Belton KJ
    Eur J Clin Pharmacol; 1997; 52(6):423-7. PubMed ID: 9342576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reporting of side-effects--a system in need of improvement. Reporting of a physician questionnaire].
    Ekbom Y; Hedenmalm K; Dalin L; Lönnroth K; Persson I
    Lakartidningen; 2002 Aug; 99(34):3290-5. PubMed ID: 12362847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitudes to adverse drug reaction reporting by medical practitioners in a Northern Italian district.
    Cosentino M; Leoni O; Banfi F; Lecchini S; Frigo G
    Pharmacol Res; 1997 Feb; 35(2):85-8. PubMed ID: 9175573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drug reaction reporting by general medical practitioners and retail pharmacists in Harare--a pilot study.
    Ball D; Tisócki T
    Cent Afr J Med; 1998 Aug; 44(8):190-5. PubMed ID: 10101417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
    Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
    Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia.
    Ali MD; Hassan YA; Ahmad A; Alaqel O; Al-Harbi H; Al-Suhaimi NM
    Curr Drug Saf; 2018; 13(1):21-25. PubMed ID: 29256354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacists' attitudes towards the reporting of suspected adverse drug reactions in Norway.
    Granas AG; Buajordet M; Stenberg-Nilsen H; Harg P; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):429-34. PubMed ID: 16953518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facing suspected child abuse--what keeps Swedish general practitioners from reporting to child protective services?
    Talsma M; Bengtsson Boström K; Östberg AL
    Scand J Prim Health Care; 2015 Mar; 33(1):21-6. PubMed ID: 25676563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.